NEW YORK – Oxford Nanopore Technologies disclosed Tuesday that it has filed an ex parte application in the US District Court for the Northern District of California to serve subpoenas on Complete Genomics, Innomics (formerly known as BGI Americas), MGI Americas, and other entities to support a lawsuit that it intends to file in the courts of England and Wales..

纽约——牛津纳米孔技术公司周二透露，它已向美国地区法院提交了一份单方面申请，要求加州北区法院对Complete Genomics、Innomics（以前称为BGI Americas）、MGI Americas和其他实体发出传票，以支持它打算在英格兰和威尔士法院提起的诉讼。。

According to a regulatory filing, Oxford Nanopore said it plans to sue BGI Tech Solutions, BGI Group, BGI, Beijing Genomics Institute at Shenzhen, MGI Holdings, and MGI Tech in England for breach of contractual obligations, common law obligations of confidence, and duties under the Trade Secrets Regulations 2018.

根据监管文件，牛津纳米孔表示，它计划起诉BGI Tech Solutions、BGI Group、BGI、深圳北京基因组研究所、MGI Holdings和英国MGI Tech违反合同义务、普通法保密义务以及2018年《商业秘密条例》规定的义务。

Oxford Nanopore also said it will file an entitlement claim to a license of certain patents. .

Oxford Nanopore还表示，它将对某些专利的许可提出权利要求。

Oxford Nanopore said it 'does not believe BGI's nanopore-based sequencing technology is able to be used in commercial products around the world without infringing or misappropriating the group's substantial portfolio of proprietary rights.'

Named CycloneSeq, BGI's nanopore sequencing technology was developed and recently unveiled by BGI Research, a unit of BGI Group.

BGI的纳米孔测序技术名为CycloneSeq，由BGI集团旗下的BGI Research开发并于最近发布。

As previously reported, BGI Group, formally named BGI Shenzhen, has established a new subsidiary called Hangzhou BGI Xufeng Technology that holds the IP related to CycloneSeq. Earlier this year, BGI Xufeng granted the exclusive rights to commercialize and distribute CycloneSeq globally to BGI Group-affiliate MGI Tech..

如前所述，华大基因集团（正式名称为华大基因深圳）成立了一家新的子公司，名为杭州华大基因旭峰科技，拥有CycloneSeq相关的知识产权。今年早些时候，华大基因旭峰将CycloneSeq全球商业化和分销的独家权利授予了华大基因集团旗下MGI Tech。。

On Monday, MGI officially announced the launch of two nanopore sequencers based on the CycloneSeq technology: CycloneSeq-WT02 and CycloneSeq-WY01. According to MGI's website, CycloneSeq-WT02 can accommodate two flow cells that can run independently while CycloneSeq-WY01 operates one.

周一，MGI正式宣布推出两款基于CycloneSeq技术的纳米孔测序仪：CycloneSeq-WT02和CycloneSeq-WY01。根据MGI的网站，CycloneSeq-WT02可以容纳两个可以独立运行的流通池，而CycloneSeq-WY01可以运行一个。

MGI said the CycloneSeq-WT02 sequencer will be open for order in select countries later this year through MGI's commercial channel while CycloneSeq-WY01 will become commercially available in the first half of 2025. MGI did not immediately respond to a request to comment on which countries the sequencers will be available in.

。MGI没有立即回应有关评论测序仪将在哪些国家提供的请求。

.

.

The impending lawsuit from Oxford Nanopore is likely to further hamper the BGI affiliates' attempts to penetrate Western markets. On Monday, the US Congress passed the Biosecure Act, which specifically targets Chinese biotech companies, including BGI Group, its affiliate MGI Tech, and MGI subsidiary Complete Genomics, aiming to cut off federal funding from these entities.  .

牛津纳米孔即将提起的诉讼可能会进一步阻碍BGI附属公司渗透西方市场的尝试。周一，美国国会通过了《生物安全法案》，该法案专门针对中国生物技术公司，包括华大基因集团（BGI Group）、其子公司MGI Tech和MGI子公司Complete Genomics，旨在切断这些实体的联邦资金。。

Oxford Nanopore, BGI Group, MGI Tech, and Complete Genomics declined to comment on the pending litigation.

牛津纳米孔、华大基因集团、MGI Tech和Complete Genomics拒绝对未决诉讼发表评论。